Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2023 Feb 28;171:196. doi: 10.1016/j.wneu.2022.12.059

Letter to the Editor Regarding “The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study”

Amnuay Kleebayoon 1,, Viroj Wiwanitkit 2,3
PMCID: PMC9970831  PMID: 36869560

We would like to share ideas on the publication “The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study.1” El Naamani et al. contrasted the results of stroke patients who had received the COVID-19 vaccine and those who had not.1 Although immunization did not significantly affect stroke patient outcomes at follow-up, El Naamani et al. reported that vaccination was linked to lower rates of morbidity and mortality among stroke patients upon discharge during the pandemic.1

We both believe that those with underlying medical conditions may respond to the vaccine differently from people in good health. To get at the correct interpretation, a number of factors must be taken into account. A genuine bad reaction was one of the possible confounding factors that might have had an impact on the results of the initial dose. Examples include the COVID-19 strain, the delivery mechanism, the setting, and the recipient's co-morbidity prior to vaccination. The absence of clinical symptoms and asymptomatic COVID-19 may be related.2 If neither the preceding symptoms nor the current symptoms are present, a COVID-19 must be ruled out. The chance of cross-contamination with an unidentified SARS-Co-V2 infection cannot be completely ruled out. It is impossible to completely rule out an unidentified SARS-Co-V2 infection. It has been investigated and established that inherited genetic variation affects vaccine recipients' immunological reactions.3 More empirical clinical research should be conducted to determine whether or not the conclusions of findings from the current work are supported.

Footnotes

Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1.El Naamani K., Amllay A., Chen C.-J., et al. The effect of COVID-19 vaccines on stroke outcomes: a single-center study. World Neurosurg. 2023;170:e834–e839. doi: 10.1016/j.wneu.2022.11.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Joob B., Wiwanitkit V. Letter to the editor: coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health. 2020;53:70. doi: 10.3961/jpmph.20.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Čiučiulkaitė I., Möhlendick B., Thümmler L., et al. GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet. 2022;13:932043. doi: 10.3389/fgene.2022.932043. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from World Neurosurgery are provided here courtesy of Elsevier

RESOURCES